NAPP PHARMACEUTICALS LIMITED
Company Information
- Company Number
- 03690299
- Registered Address
- Unit 196 Cambridge Science Park, Milton Road, Cambridge, England, CB4 0AB
- Status
- Active
- Employee Count
- 49
- Turnover
- £70,404,000
- EBITDA
- £1,683,000
Additional Details
- Website
- https://www.napp.co.uk/
- Company Type
- Private limited Company
- Incorporated On
- 22 December 1998
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 31 Jan 2024 | 27 | 70% | 22% | 8% | 15% |
| 01 Jan 2022 - 30 Jun 2022 | 22 Jul 2022 | 33 | 58% | 33% | 8% | 34% |
| 01 Jul 2021 - 31 Dec 2021 | 30 Jan 2022 | 33 | 52% | 38% | 10% | 53% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 37 | 30% | 61% | 9% | 71% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 35 | 38% | 56% | 6% | 67% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 25 | 78% | 22% | 1% | 17% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 30 | 71% | 24% | 6% | 26% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 29 | 68% | 26% | 6% | 29% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 30 | 64% | 30% | 6% | 36% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The default position is 90 days, however there may be changes to this default position on a case-by-case basis pending agreement with suppliers. On a case-by-case basis, payment terms to suppliers may be immediate payment or payment on terms within 7, 14, 30 or 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
If a supplier has a query or dispute relating to a payment they believe is owed to them by Napp Pharmaceuticals Limited (NPL), the supplier is to please email the below details, to napp.apqueries@mundipharma.com a. Full supplier name, address; b. The name of your NPL point of contact; c. Invoice number for the payment you are querying; d. Full details of your complaint; e. Upon receipt of all of the above details, NPL commits to acknowledge receipt of the supplier email within five working days, and may request further information to be able to respond in full. NPL will investigate the supplier query using the details provided and speak with relevant members of NPL’s business, including members of NPL’s legal department if necessary, and respond in full within 14 days of the date of NPL’s acknowledgement to the supplier.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
NAPP PHARMACEUTICALS LIMITED is a UK-based pharmaceutical company that specializes in the research, development, and production of medicines for various diseases and conditions. Founded in 1923, the company has been providing high-quality and innovative healthcare solutions for almost a century.
The company has a strong focus on sustainability and has implemented various programs to reduce their environmental impact. They have set targets to reduce their carbon footprint, increase energy efficiency, and minimize waste generation. Their sustainability efforts have been recognized by various organizations, including being listed on the Dow Jones Sustainability Index.
NAPP PHARMACEUTICALS LIMITED offers a wide range of products and services, including prescription medicines, over-the-counter medicines, and medical devices. Their portfolio includes treatments for respiratory diseases, pain management, neurological disorders, and more. They also provide support and resources for healthcare professionals and patients to ensure the best possible outcomes.
The key people at NAPP PHARMACEUTICALS LIMITED include CEO Michael Lavery, who has been with the company since 2015 and has over 25 years of experience in the pharmaceutical industry. The company also has a team of experienced scientists, researchers, and healthcare professionals dedicated to developing and delivering effective and safe medicines.
For more information, interested parties can visit their website at www.napp.co.uk. The company's registered office address is NAPP House, Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, United Kingdom. Overall, NAPP PHARMACEUTICALS LIMITED is committed to providing sustainable and innovative healthcare solutions and is a leader in the pharmaceutical industry.
